Home » Topics » BioWorld Science

BioWorld Science
RSS

Boehringer Ingelheim and Yuhan collaborate on GLP1R/FGF21R agonist for NASH

July 2, 2019

Boston Biomedical to discontinue CanStem111P study of napabucasin in pancreatic cancer

July 2, 2019

European Commission approves Libtayo for advanced cutaneous squamous cell carcinoma

July 2, 2019

Shanghai Meiyue Biotech presents new thrombin inhibitors

July 2, 2019

Esteve Pharmaceuticals patent describes analgesic agents

July 2, 2019

GlaxoSmithKline synthesizes new IDO1 inhibitors

July 2, 2019

Parkinson's disease starts in gut, moves to brain: study

July 2, 2019

Boehringer Ingelheim patents GluN2B negative allosteric modulators

July 2, 2019

SciFluor Life Sciences divulges KCNQ2/3 activators

July 2, 2019

Results from phase II study presented for sintilimab in patients with R/R ENKTL

July 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...